BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35068159)

  • 21. Biological features and clinical outcome in infant neuroblastoma: a multicenter experience in Beijing.
    Zhang S; Zhang W; Jin M; Sun Q; Zhang Z; Qin H; Su Y; Zhi T; Xie Y; Gao YX; Zhang X; Li L; Liu R; Zhao W; Wang H; Huang D; Ma X
    Eur J Pediatr; 2021 Jul; 180(7):2055-2063. PubMed ID: 33580827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma.
    Dhooge CR; De Moerloose BM; Benoit YC; Van Roy N; Philippé ; Laureys GG
    Cancer; 1997 Oct; 80(7):1250-7. PubMed ID: 9317175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and risk factors of 47 cases with ruptured neuroblastoma in children.
    Qin H; Yang S; Cai S; Ren Q; Han W; Yang W; Cheng H; Ma X; Wang H
    BMC Cancer; 2020 Mar; 20(1):243. PubMed ID: 32293329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.
    Yan P; Qi F; Bian L; Xu Y; Zhou J; Hu J; Ren L; Li M; Tang W
    Med Sci Monit; 2020 Nov; 26():e927218. PubMed ID: 33249420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State of the art in immunotherapy of neuroblastoma.
    Jabbari P; Hanaei S; Rezaei N
    Immunotherapy; 2019 Jun; 11(9):831-850. PubMed ID: 31094257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
    De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
    Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004.
    Jazmati D; Butzer S; Hero B; Doyen J; Ahmad Khalil D; Steinmeier T; Schulze Schleithoff S; Eggert A; Simon T; Timmermann B
    Strahlenther Onkol; 2021 Aug; 197(8):683-689. PubMed ID: 33300099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
    Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
    J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.
    Mora J; Gerald WL; Cheung NK
    Cancer Lett; 2003 Jul; 197(1-2):119-24. PubMed ID: 12880970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD
    Mueller I; Ehlert K; Endres S; Pill L; Siebert N; Kietz S; Brock P; Garaventa A; Valteau-Couanet D; Janzek E; Hosten N; Zinke A; Barthlen W; Varol E; Loibner H; Ladenstein R; Lode HN
    MAbs; 2018 Jan; 10(1):55-61. PubMed ID: 29120699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G
    Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Kramer K; Modak S; Yataghene K; Cheung NK
    Oncoimmunology; 2015 Jul; 4(7):e1016704. PubMed ID: 26140243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
    Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
    Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroblastoma: prognostic factors and survival. Experience in Hospital de Pediatria del Centro Medico Nacional del Siglo XXI and review of the literature].
    López-Aguilar E; Cerecedo-Díaz F; Rivera-Márquez H; Valdéz-Sánchez M; Sepúlveda-Vildósola AC; Delgado Huerta S; Vera-Hermosillo H; Vázquez-Langle JR; Wanzke del Angel V
    Gac Med Mex; 2003; 139(3):209-14. PubMed ID: 12872413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M
    Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of surgical radicality on outcome in childhood neuroblastoma.
    von Schweinitz D; Hero B; Berthold F
    Eur J Pediatr Surg; 2002 Dec; 12(6):402-9. PubMed ID: 12548494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.
    Zobel MJ; Zamora AK; Wu HW; Sun J; Lascano D; Malvar J; Wang L; Sheard MA; Seeger RC; Kim ES
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gangliosides and Neuroblastomas.
    Schengrund CL
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.